• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Chinese Journal of Infection and Chemotherapy

    Chinese Journal of Infection and Chemotherapy

    JournalISSN 1009-7708

    年发文量

    研究主题

    论文(3106)

    排序
    1Atypical Pneumonia Caused by Chlamydia Abortus in HIV Patient: a Case Report
    Mengyan Wang,Binhai Zhang,Hu Wan,Lele Yu

    BACKGROUND:Chlamydia abortus, as a pathogen of atypical pneumonia, is rare in humans, especially in HIV infection patients. CASE PRESENTATION:We present the case of a 48-year-old man with a history of HIV infection who started high fever and developed pneumonia. The pathogen-targeted next-generation sequencing (ptNGS) results of bronchial lavage fluid showed Chlamydia abortus infection. CONCLUSION:This is the first report of Chlamydia abortus infection presented as atypical pneumonia in an AIDS patient.

    2024引用:3
    引用
    AI阅读
    加入学术空间
    2Guidelines for the Diagnosis, Treatment, Prevention and Control of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli
    Mei Zeng,Jun Xia,Zhiyong Zong,Yi Shi,Yuxing Ni,Fupin Hu,Yijian Chen,Chao Zhuo,Bijie Hu,Jiabin Li,Zhengyin Liu,Jing Zhang,

    The dissemination of carbapenem-resistant Gram-negative bacilli (CRGNB) is a global public health issue. CRGNB isolates are usually extensively drug-resistant or pandrugresistant, resulting in limited antimicrobial treatment options and high mortality. A multidisciplinary guideline development group covering clinical infectious diseases, clinical microbiology, clinical pharmacology, infection control, and guideline methodology experts jointly developed the present clinical practice guidelines based on best available scientific evidence to address the clinical issues regarding laboratory testing, antimicrobial therapy, and prevention of CRGNB infections. This guideline focuses on carbapenem-resistant Enterobacteriales (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB), and carbapenem-resistant Pseudomonas aeruginosa (CRPA). Sixteen clinical questions were proposed from the perspective of current clinical practice and translated into research questions using PICO (population, intervention, comparator, and outcomes) format to collect and synthesize relevant evidence to inform corresponding recommendations. The grading of recommendations, assessment, development and evaluation (GRADE) approach was used to evaluate the quality of evidence, benefit and risk profile of corresponding interventions and formulate recommendations or suggestions. Evidence extracted from systematic reviews and randomized controlled trials (RCTs) was considered preferentially for treatment-related clinical questions. Observational studies, non-controlled studies, and expert opinions were considered as supplementary evidence in the absence of RCTs. The strength of recommendations was classified as strong or conditional (weak). The evidence informing recommendations derives from studies worldwide, while the implementation suggestions combined the Chinese experience. The target audience of this guideline is clinician and related professionals involved in management of infectious diseases. Copyright 2023, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

    2024引用:120
    引用
    AI阅读
    加入学术空间
    3Incidence and risk factors of voriconazole-induced liver injury in the context of therapeutic drug monitoring
    LIN Liangmo,HONG Mianhui,WU Danna,ZHONG Lili,FU Xiangjun

    目的 分析海南省人民医院临床使用伏立康唑致肝损伤的发生情况,探索可能的影响因素.方法 将研究期间使用伏立康唑并接受血药浓度监测且起始肝功能正常的患者纳入研究,根据用药后肝功能检查结果将患者分为未发生肝损伤组和发生肝损伤组.采用单因素及二元logistic回归分析伏立康唑致肝损伤的危险因素,并使用受试者工作特征(ROC)曲线确定各个危险因素预测性能的灵敏度、特异度和最佳截点.结果 共有 116 例患者纳入研究,肝损伤发生率为 28.4%.单因素和多因素分析结果显示血药谷浓度及感染指标C反应蛋白(CRP)是伏立康唑致肝损伤的危险因素,血药谷浓度>4.80 mg/L及CRP>127.86 mg/L的患者肝损伤风险显著增加.结论 对于CRP较高的患者使用伏立康唑期间应当密切监测血药浓度以降低肝损伤风险.

    2023
    引用
    AI阅读
    加入学术空间
    4Antimicrobial resistance of the pathogens isolated from pharyngeal swabs of 1476 hematopoietic stem cell transplantation recipients
    GE Jianrong,WU Xiaojin,WU Depei,LIU Jisheng

    Objective To investigate the distribution and antimicrobial resistance of the potential pathogens isolated from pharyngeal swabs of hematopoietic stem cell transplantation(HSCT) recipients. Methods A total of 1 476 consecutive patients who underwent HSCT in the First Affiliated Hospital of Soochow University from January 1, 2018 to December 31, 2020 were enrolled. Pharyngeal swab was taken every week starting from the first day after admission to transplant wards until discharge. The detection rate, distribution,and antimicrobial resistance of the pathogens isolated from pharyngeal swabs were compared between allogeneic transplantation recipients and autologous transplantation recipients retrospectively. Results Overall, 176 strains of pathogens were isolated from 176 of the 1 476 HSCT recipients by pharyngeal swabs. The detection rate was 11.92%. Most(93.18%, 164/176) of the isolates were Gram-negative bacteria, including Enterobacteriaceae and non-fermenting Gram-negative bacteria. The top five species were Klebsiella pneumoniae(23.30%, 41/176), Stenotrophomonas maltophilia(21.59%, 38/176), Burkholderia cepacia(15.91%, 28/176), Enterobacter cloacae(10.80%, 19/176), and Acinetobacter baumannii(9.66%, 17/176). There were 12(6.82%) strains of Gram-positive bacteria, including Staphylococcus aureus(3.98%, 7/176) and Staphylococcus epidermidis(1.70%, 3/176). Antimicrobial susceptibility testing showed that more than 50% of K. pneumoniae and E. cloacae isolates were resistant to ampicillin, piperacillin, ceftriaxone, levofloxacin and cotrimoxazole, while less than 20% of the isolates were resistant to imipenem. Not more than 40% of S. maltophilia and B. cepacia isolates were resistant to cefoperazone-sulbactam, ceftazidime, levofloxacin, trimethoprim-sulfamethoxazole, or minocycline. About 40% of A. baumannii strains were resistant to ceftriaxone, less than 30% resistant to cefoperazone-sulbactam, nearly 10% resistant to amikacin, and higher than 70% resistant to imipenem. The detection rate, distribution and antimicrobial resistance of Gram-negative bacteria did not show significant difference between allogeneic transplantation recipients and autologous transplantation recipients(P > 0.05). Conclusions Pharyngeal swab culture during hematopoietic stem cell transplantation is conducive to screening potential pharyngeal pathogens, which can inform the rational use of antibiotics and effective prevention and treatment of infections.

    2023
    引用
    AI阅读
    加入学术空间
    5Expert consensus on antimicrobial synergy testing and reporting of carbapenem-resistant Gram-negative bacteria
    DING Li,CHEN Baiyi,LI Min,NI Yuxing,SHAN Bin,SU Danhong,SUN Ziyong,YANG Qiwen,YU Hua,YU Yunsong,ZHANG Lixia, ZHANG Rong,

    1 前言 碳青霉烯类抗菌药物包括亚胺培南、美罗培南和厄他培南等,是治疗多重耐药革兰阴性菌所致感染最有效的抗菌药物之一.随着该类药物在临床的广泛使用,碳青霉烯类耐药细菌(carbapenem-resistant organisms, CRO)的检出率呈逐年上升趋势,其中以肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌为代表.CHINET中国细菌耐药监测网2021年监测结果显示,我国临床分离肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌对亚胺培南的耐药率分别为23.1%、23%和71.5%[1-2].

    2023引用:7
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3106 篇论文

    高被引作者

    作者引用发文
    GuangHui Li1837437
    Fu Wang795584
    Yingchun Xu7784112
    Demei Zhu7186125
    Yuxing Ni7123100
    Yunsong Yu687682
    Fupin Hu6785103
    DanHong Su678063
    Jingyong Sun640785
    Ziyong Sun633388

    高产作者

    作者引用发文
    Yingchun Xu7784112
    Fupin Hu6785103
    Yuxing Ni7123100
    Ziyong Sun633388
    Jingyong Sun640785
    Fu Wang795584
    Yunsong Yu687682
    YingYuan Zhang118976
    Chuanqing Wang614673
    Chao Zhuo600867

    相关期刊

    Chinese Journal of Antituberculosis
    Chinese Journal of Drug Application and Monitoring
    Chinese Journal of Mycology
    Journal of Clinical Transfusion and Laboratory Medicine
    Chinese Journal of Blood Transfusion
    Chinese Journal of Infectious Diseases
    Chinese Journal of Tuberculosis and Respiratory Diseases
    Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
    Electronic Journal of Emerging Infectious Diseases
    Clinical Medication Journal